AQMS
Aqua Metals, Inc.
There isn't enough reported data to score AQMS yet.
BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
AQMS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AQMS's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
AQMS PE Valuation
AQMS has no meaningful PE right now: it lost money over the past year.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
AQMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect AQMS's losses to grow, with revenue declining.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
AQMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$9.21 | +$26.83 |
| Q1 2026 | -$15.34 | +$23.26 |
| Q4 2025 | -$24.42 | +$13.88 |
| Q3 2025 | -$30.63 | +$18.32 |
| Q2 2025 | -$36.04 | +$13.31 |
| Q1 2025 | -$38.60 | +$12.75 |
| Q4 2024 | -$38.30 | +$15.05 |
| Q3 2024 | -$48.95 | -$6.48 |
AQMS is still losing money, but far less than before: $9.21 per share over the past year, against $206.00 at its worst in late 2019.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over AQMS on earnings quality, reporting a profit while its opponent remains loss making.
AQMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2020 | $90K | -96% |
BA has the stronger quarterly revenue trend. Revenue is down 100% for AQMS versus up 3.9% for BA.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | -19796% | N/A |
| Q2 2022 | -98875% | N/A |
| Q4 2021 | -2428% | N/A |
| Q3 2020 | -3790% | -3313 points |
| Q1 2020 | -22572% | N/A |
| Q4 2019 | -1734% | N/A |
| Q3 2019 | -477% | N/A |
AQMS's operating margin was −19796% last quarter, up 2776 points from the same quarter a year ago.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
AQMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$48K |
| Q1 2026 | -$3.8M | -$802K |
| Q4 2025 | -$2.6M | -$145K |
| Q3 2025 | -$2.3M | +$2.3M |
| Q2 2025 | -$2.7M | +$4.8M |
| Q1 2025 | -$3M | +$3.9M |
| Q4 2024 | -$2.5M | +$2.4M |
| Q3 2024 | -$4.6M | -$758K |
AQMS has burned cash in almost every quarter: −$11M over the past year, against −$13M the year before.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over AQMS on cash generation, producing positive trailing cash flow while its opponent burns cash.
AQMS Net Leverage
AQMS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
AQMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.8 | Neutral |
| Stochastic | 11.6 | Oversold |
AQMS's weekly RSI is 32 (neutral) and its Stochastic is 12 (oversold).
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
AQMS PE vs Industrials Sector
AQMS has no meaningful PE right now: it lost money over the past year.
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
AQMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.77 | 23% below |
| 20 week MA | $2.32 | 41% below |
| 50 week MA | $3.70 | 63% below |
| 100 week MA | $7.76 | 82% below |
| 200 week MA | $75.2 | 98% below |
AQMS is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
AQMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $166.0 | $468.0 | +182% |
| 2021 | $468.0 | $276.0 | -41% |
| 2022 | $276.0 | $148.0 | -46% |
| 2023 | $148.0 | $152.0 | +2.7% |
| 2024 | $152.0 | $26.2 | -83% |
| 2025 | $26.2 | $4.85 | -81% |
| 2026 YTD | $4.85 | $1.37 | -72% |
AQMS's yearly returns have swung widely, from +182% in 2020 to −83% in 2024. It's down 72% so far in 2026.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over AQMS on returns for 2026, with the stronger performance.